To what level of detail we will need to understand the individual components and/or the modules to make meaningful predictions about cellular outcome is still unclear, but we argue that both a quantitative view of the PTMs and introduction of a spatial and temporal picture of the different determinants and mediators will probably be required to understand signal transduction in terms of cellular, organ, and patient outcomes.
